The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Role of advanced glycation end products in cardiovascular disease
Open accessAbstract
Advanced glycation end products (AGEs) are produced through the non enzymatic glycation and oxidation of proteins, lipids and nucleic acids. Enhanced formation of AGEs occurs particularly in conditions associated with hyperglycaemia such as diabetes mellitus (DM). AGEs are believed to have a key role in the development and progression of cardiovascular disease in patients with DM through the modification of the structure, function and mechanical properties of tissues through crosslinking intracellular as well as extracellular matrix proteins and through modulating cellular processes through binding to cell surface receptors [receptor for AGEs (RAGE)]. A number of studies have shown a correlation between serum AGE levels and the development and severity of heart failure (HF). Moreover, some studies have suggested that therapies targeted against AGEs may have therapeutic potential in patients with HF. The purpose of this review is to discuss the role of AGEs in cardiovascular disease and in particular in heart failure, focussing on both cellular mechanisms of action as well as highlighting how targeting AGEs may represent a novel therapeutic strategy in the treatment of HF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
Thornalley, P. J., LANGBORG, A., & Minhas, H. S. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440109 · Cited by 1,243
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M.-P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J.-L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,072
BASTA, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.05.001 · Cited by 999
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study
Gottdiener, J. S., Arnold, A. M., Aurigemma, G. P., Polak, J. F., Tracy, R. P., Kitzman, D. W., Gardin, J. M., Rutledge, J. E., & Boineau, R. C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00582-9 · Cited by 907
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Du Yan, S., Hofmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 869
Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed · Cited by 780
Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker
Kass, D. A., Shapiro, E. P., Kawaguchi, M., Capriotti, A. R., Scuteri, A., deGroof, R. C., & Lakatta, E. G. (2001) · Circulation · doi:10.1161/hc3801.097806 · Cited by 727
THORNALLEY, P. J., BATTAH, S., AHMED, N., KARACHALIAS, N., AGALOU, S., BABAEI-JADIDI, R., & DAWNAY, A. (2003) · Biochemical Journal · doi:10.1042/bj20030763 · Cited by 659
Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L., & Stern, D. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1521 · Cited by 635
Huttunen, H. J., Fages, C., & Rauvala, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19919 · Cited by 628
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins
Chavakis, T., Bierhaus, A., Al-Fakhri, N., Schneider, D., Witte, S., Linn, T., Nagashima, M., Morser, J., Arnold, B., Preissner, K. T., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030800 · Cited by 582
Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis
Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 571
RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice
Bucciarelli, L. G., Wendt, T., Qu, W., Lu, Y., Lalla, E., Rong, L. L., Goova, M. T., Moser, B., Kislinger, T., Lee, D. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039325.03698.36 · Cited by 563
Basta, G., Lazzerini, G., Massaro, M., Simoncini, T., Tanganelli, P., Fu, C., Kislinger, T., Stern, D. M., Schmidt, A. M., & De Caterina, R. (2002) · Circulation · doi:10.1161/hc0702.104183 · Cited by 544
Maillard reaction products in tissue proteins: New products and new perspectives
Thorpe, S. R., & Baynes, J. W. (2003) · Amino Acids · doi:10.1007/s00726-003-0017-9 · Cited by 543
Li, J., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16498 · Cited by 525
Liliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 524
Binding of S100 proteins to RAGE: An update
Leclerc, E., Fritz, G., Vetter, S. W., & Heizmann, C. W. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.016 · Cited by 489
Bucala, R., Makita, Z., Vega, G., Grundy, S., Koschinsky, T., Cerami, A., & Vlassara, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9441 · Cited by 474
Oldfield, M. D., Bach, L. A., Forbes, J. M., Nikolic-Paterson, D., McRobert, A., Thallas, V., Atkins, R. C., Osicka, T., Jerums, G., & Cooper, M. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11951 · Cited by 472
Bolton, W. K., Cattran, D. C., Williams, M. E., Adler, S. G., Appel, G. B., Cartwright, K., Foiles, P. G., Freedman, B. I., Raskin, P., Ratner, R. E., et al. (2004) · American Journal of Nephrology · doi:10.1159/000075627 · Cited by 461
Candido, R., Forbes, J. M., Thomas, M. C., Thallas, V., Dean, R. G., Burns, W. C., Tikellis, C., Ritchie, R. H., Twigg, S. M., Cooper, M. E., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000065620.39919.20 · Cited by 448
Genuth, S., Sun, W., Cleary, P., Sell, D. R., Dahms, W., Malone, J., Sivitz, W., Monnier, V. M., & for the DCCT Skin Collagen Ancillary Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.11.3103 · Cited by 427
Advanced glycation end products increase retinal vascular endothelial growth factor expression.
Lu, M., Kuroki, M., Amano, S., Tolentino, M., Keough, K., Kim, I., Bucala, R., & Adamis, A. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1277 · Cited by 423
Kannel, W. B. (1976) · BMJ · doi:10.1136/bmj.2.6046.1255-a · Cited by 394
Cipollone, F., Iezzi, A., Fazia, M., Zucchelli, M., Pini, B., Cuccurullo, C., De Cesare, D., De Blasis, G., Muraro, R., Bei, R., et al. (2003) · Circulation · doi:10.1161/01.cir.0000086014.80477.0d · Cited by 377
Thrainsdottir, I. S., Aspelund, T., Thorgeirsson, G., Gudnason, V., Hardarson, T., Malmberg, K., Sigurdsson, G., & Rydén, L. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.612 · Cited by 374
Role of the Maillard Reaction in Aging of Tissue Proteins
Frye, E. B., Degenhardt, T. P., Thorpe, S. R., & Baynes, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18714 · Cited by 366
Identification, classification, and expression of RAGE gene splice variants
Hudson, B. I., Carter, A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., Grant, P. J., & Schmidt, A. M. (2008) · The FASEB Journal · doi:10.1096/fj.07-9909com · Cited by 360
Structural Basis for Activation of the Receptor Tyrosine Kinase KIT by Stem Cell Factor
Yuzawa, S., Opatowsky, Y., Zhang, Z., Mandiyan, V., Lax, I., & Schlessinger, J. (2007) · Cell · doi:10.1016/j.cell.2007.05.055 · Cited by 359
Hudson, B. I., Kalea, A. Z., del Mar Arriero, M., Harja, E., Boulanger, E., D'Agati, V., & Schmidt, A. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801465200 · Cited by 358
Veves, A., Akbari, C. M., Primavera, J., Donaghue, V. M., Zacharoulis, D., Chrzan, J. S., DeGirolami, U., LoGerfo, F. W., & Freeman, R. (1998) · Diabetes · doi:10.2337/diabetes.47.3.457 · Cited by 349
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis
Yan, S. D., Zhu, H., Zhu, A., Golabek, A., Du, H., Roher, A., Yu, J., Soto, C., Schmidt, A. M., Stern, D., et al. (2000) · Nature Medicine · doi:10.1038/76216 · Cited by 343
Advanced glycation end-products and the progress of diabetic vascular complications.
Jakuš, V, & Rietbrock, N. (2004) · Physiological Research · doi:10.33549/physiolres.930430 · Cited by 341
RAGE: a single receptor fits multiple ligands
Fritz, G. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.08.008 · Cited by 340
Asif, M., Egan, J., Vasan, S., Jyothirmayi, G. N., Masurekar, M. R., Lopez, S., Williams, C., Torres, R. L., Wagle, D., Ulrich, P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040558497 · Cited by 335
THORPE SR ROLE OF OXIDATIVE STRESS IN DIABETIC COMPLICATIONS: A NEW PERSPECTIVE ON AN OLD PARADIGM
Baynes, J. (1999) · Cited by 326
Stitt, A. W., Li, Y. M., Gardiner, T. A., Bucala, R., ARCHER, D. B., & Vlassara, H. (1997) · Europe PMC (PubMed Central) · Cited by 324
Koyama, H., Shoji, T., Yokoyama, H., Motoyama, K., Mori, K., Fukumoto, S., Emoto, M., Shoji, T., Tamei, H., Matsuki, H., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000190660.32863.cd · Cited by 313
Sell, D. R., Lapolla, A., Odetti, P., Fogarty, J., & Monnier, V. M. (1992) · Diabetes · doi:10.2337/diab.41.10.1286 · Cited by 310
Advanced glycation: an important pathological event in diabetic and age related ocular disease
STITT, A. W. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.6.746 · Cited by 306
Little, W. C., Zile, M. R., Kitzman, D. W., Hundley, W. G., O'Brien, T. X., & deGroof, R. C. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.09.010 · Cited by 299
Advanced Glycation End-Products (AGEs) and Heart Failure: Pathophysiology and Clinical Implications
Hartog, J. W. L., Voors, A. A., Bakker, S. J. L., Smit, A. J., & van Veldhuisen, D. J. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.09.009 · Cited by 299
Diastolic Dysfunction and Diabetic Cardiomyopathy
Galderisi, M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.033 · Cited by 279
Kilhovd, B. K., Berg, T. J., Birkeland, K. I., Thorsby, P., & Hanssen, K. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1543 · Cited by 269
Stirban, A., Negrean, M., Stratmann, B., Gawlowski, T., Horstmann, T., Götting, C., Kleesiek, K., Mueller-Roesel, M., Koschinsky, T., Uribarri, J., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0531 · Cited by 259
SUZUKI, D., MIYATA, T., SAOTOME, N., HORIE, K., INAGI, R., YASUDA, Y., UCHIDA, K., IZUHARA, Y., YAGAME, M., SAKAI, H., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104822 · Cited by 254
Williams, M. E., Bolton, W. K., Khalifah, R. G., Degenhardt, T. P., Schotzinger, R. J., & McGill, J. B. (2007) · American Journal of Nephrology · doi:10.1159/000108104 · Cited by 253
Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)
Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D. S., & Shekhtman, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801622200 · Cited by 252
McDonald, D. R., Bamberger, M. E., Combs, C. K., & Landreth, G. E. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04451.1998 · Cited by 252
Structural Basis for Ligand Recognition and Activation of RAGE
Koch, M., Chitayat, S., Dattilo, B. M., Schiefner, A., Diez, J., Chazin, W. J., & Fritz, G. (2010) · Structure · doi:10.1016/j.str.2010.05.017 · Cited by 244
Sugaya, K., Fukagawa, T., Matsumoto, K.-I., Mita, K., Takahashi, E.-I., Ando, A., Inoko, H., & Ikemura, T. (1994) · Genomics · doi:10.1006/geno.1994.1517 · Cited by 242
Nin, J. W., Jorsal, A., Ferreira, I., Schalkwijk, C. G., Prins, M. H., Parving, H.-H., Tarnow, L., Rossing, P., & Stehouwer, C. D. (2011) · Diabetes Care · doi:10.2337/dc10-1087 · Cited by 242
Gerrits, E. G., Lutgers, H. L., Kleefstra, N., Graaff, R., Groenier, K. H., Smit, A. J., Gans, R. O., & Bilo, H. J. (2008) · Diabetes Care · doi:10.2337/dc07-1755 · Cited by 233
Bidasee, K. R., Zhang, Y., Shao, C. H., Wang, M., Patel, K. P., Dincer, U. D., & Besch, H. R. (2004) · Diabetes · doi:10.2337/diabetes.53.2.463 · Cited by 229
Renal catabolism of advanced glycation end products: the fate of pentosidine
Miyata, T., Ueda, Y., Horie, K., Nangaku, M., Tanaka, S., de Strihou, C. V. Y., & Kurokawa, K. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00756.x · Cited by 227
Therapeutic potential of breakers of advanced glycation end product–protein crosslinks
Vasan, S., Foiles, P., & Founds, H. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.016 · Cited by 221
Advanced Glycation End Product Recognition by the Receptor for AGEs
Xue, J., Rai, V., Singer, D., Chabierski, S., Xie, J., Reverdatto, S., Burz, D. S., Schmidt, A. M., Hoffmann, R., & Shekhtman, A. (2011) · Structure · doi:10.1016/j.str.2011.02.013 · Cited by 217
Murata, T., Nagai, R., Ishibashi, T., Inomata, H., Ikeda, K., & Horiuchi, S. (1997) · Diabetologia · doi:10.1007/s001250050747 · Cited by 201
Norton, G. R., Candy, G., & Woodiwiss, A. J. (1996) · Circulation · doi:10.1161/01.cir.93.10.1905 · Cited by 197
Neumann, A., Schinzel, R., Palm, D., Riederer, P., & Münch, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00731-0 · Cited by 195
Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy
Corman, B., Duriez, M., Poitevin, P., Heudes, D., Bruneval, P., Tedgui, A., & Levy, B. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1301 · Cited by 190
Meerwaldt, R., Links, T. P., Graaff, R., Hoogenberg, K., Lefrandt, J. D., Baynes, J. W., Gans, R. O. B., & Smit, A. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1828-x · Cited by 181
Cai, W., He, J. C., Zhu, L., Peppa, M., Lu, C., Uribarri, J., & Vlassara, H. (2004) · Circulation · doi:10.1161/01.cir.0000135587.92455.0d · Cited by 177
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
Meerwaldt, R., Links, T., Zeebregts, C., Tio, R., Hillebrands, J.-L., & Smit, A. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-29 · Cited by 175
Miura, J., Yamagishi, S., Uchigata, Y., Takeuchi, M., Yamamoto, H., Makita, Z., & Iwamoto, Y. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00183-6 · Cited by 170
Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro
Kent, M. J. C., Light, N. D., & Bailey, A. J. (1985) · Biochemical Journal · doi:10.1042/bj2250745 · Cited by 166
Zieman, S. J., & Kass, D. A. (2004) · Drugs · doi:10.2165/00003495-200464050-00001 · Cited by 166
Xie, J., Burz, D. S., He, W., Bronstein, I. B., Lednev, I., & Shekhtman, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608888200 · Cited by 165
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Sugiyama, S., Miyata, T., Ueda, Y., Tanaka, H., Maeda, K., Kawashima, S., Van Ypersele de Strihou, C., & Kurokawa, K. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v991681 · Cited by 162
Immunohistochemical and ELISA Assays for Biomarkers of Oxidative Stress in Aging and Diseasea
Onorato, J. M., Thorpe, S. R., & Baynes, J. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09909.x · Cited by 161
Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats
Lagadic-Gossmann, D., Buckler, K. J., Le Prigent, K., & Feuvray, D. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.5.h1529 · Cited by 159
The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940900101x · Cited by 158
Decreased Endogenous Secretory Advanced Glycation End Product Receptor in Type 1 Diabetic Patients
Katakami, N., Matsuhisa, M., Kaneto, H., Matsuoka, T., Sakamoto, K., Nakatani, Y., Ohtoshi, K., Hayaishi-Okano, R., Kosugi, K., Hori, M., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2716 · Cited by 155
Kaji, Y., Usui, T., Ishida, S., Yamashiro, K., Moore, T., Moore, J. E., Yamamoto, Y., Yamamoto, H., & Adamis, A. P. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0495 · Cited by 153
Li, L. (2006) · PubMed · Cited by 141
Lapolla, A., Piarulli, F., Sartore, G., Ceriello, A., Ragazzi, E., Reitano, R., Baccarin, L., Laverda, B., & Fedele, D. (2007) · Diabetes Care · doi:10.2337/dc06-1508 · Cited by 140
Yoshida, N., Okumura, K.-I., & Aso, Y. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.014 · Cited by 138
Formation of Crossline as a Fluorescent Advanced Glycation End Productin Vitroandin Vivo
Obayashi, H., Nakano, K., Shigeta, H., Yamaguchi, M., Yoshimori, K., Fukui, M., Fujii, M., Kitagawa, Y., Nakamura, N., Nakamura, K., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1308 · Cited by 137
Bidasee, K. R., Nallani, K. C., Yu, Y., Cocklin, R., Zhang, Y., Wang, M., Dinçer, Ü. D., & Besch, H. R. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1825 · Cited by 137
Soulis, T., Cooper, M. E., Dunlop, M., & Jerums, G. (1995) · Diabetologia · doi:10.1007/bf00410275 · Cited by 136
Site-Specific Blockade of RAGE-VdPrevents Amyloid-β Oligomer Neurotoxicity
Sturchler, E., Galichet, A., Weibel, M., Leclerc, E., & Heizmann, C. W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4878-07.2008 · Cited by 136
Koyama, Y., Takeishi, Y., Arimoto, T., Niizeki, T., Shishido, T., Takahashi, H., Nozaki, N., Hirono, O., Tsunoda, Y., Nitobe, J., et al. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.11.009 · Cited by 135
The effect of non-enzymatic glycation on the unfolding of human serum albumin
Mendez, D. L., Jensen, R. A., McElroy, L. A., Pena, J. M., & Esquerra, R. M. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.10.019 · Cited by 133
Diabetes, advanced glycation endproducts and vascular disease
Wautier, J., & Guillausseau, P.-J. (1998) · Vascular Medicine · doi:10.1177/1358836x9800300207 · Cited by 128
Advanced Glycation End Products Induce Blood–Retinal Barrier Dysfunction in Normoglycemic Rats
Stitt, A. W., Bhaduri, T., McMullen, C. B. T., Gardiner, T. A., & ARCHER, D. B. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0243 · Cited by 127
Kiuchi, K., Nejima, J., Takano, T., Ohta, M., & Hashimoto, H. (2001) · Heart · doi:10.1136/heart.85.1.87 · Cited by 127
Hartog, J. W. L., Willemsen, S., van Veldhuisen, D. J., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr067 · Cited by 124
The effect of advanced glycation end-product formation upon cell-matrix interactions
Paul, R. G., & Bailey, A. J. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00023-0 · Cited by 118
Schram, M. T., Schalkwijk, C. G., Bootsma, A. H., Fuller, J., Chaturvedi, N., & Stehouwer, C. D. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000164574.60279.ba · Cited by 116
Wilkinson‐Berka, J. L., Kelly, D. J., Koerner, S. M., Jaworski, K., Davis, B., Thallas, V., & Cooper, M. E. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3283 · Cited by 105
Min, C., Kang, E., Yu, S.-H., Shinn, S.-H., & Kim, Y. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00094-7 · Cited by 97
He, C., Koschinsky, T., Bünting, C. E., & Vlassara, H. (2001) · Molecular Medicine · doi:10.1007/bf03401949 · Cited by 93
Advanced glycation endproducts: A biomarker for age as an outcome predictor after cardiac surgery?
Simm, A., Wagner, J., Gursinsky, T., Naß, N., Friedrich, I., Schinzel, R., Czeslick, E. G., Silber, R.-E., & Scheubel, R. J. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.03.006 · Cited by 91
ELISA of pentosidine, an advanced glycation end product, in biological specimens
Taneda, S., & Monnier, V. M. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.9.1766 · Cited by 89
Oral benfotiamine plus α-lipoic acid normalises complication-causing pathways in type 1 diabetes
Du, X., Edelstein, D., & Brownlee, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1100-2 · Cited by 88
Glycated proteins in diabetes.
Furth, A. J. (1997) · PubMed · Cited by 86
Penfold, S. A., Coughlan, M. T., Patel, S. K., Srivastava, P., Sourris, K. C., Steer, D. L., Webster, D. E., Thomas, M. C., MacIsaac, R. J., Jerums, G., et al. (2010) · Kidney International · doi:10.1038/ki.2010.134 · Cited by 79
Willemsen, S., Hartog, J. W. L., Hummel, Y. M., van Ruijven, M. H., van der Horst, I. C. C., van Veldhuisen, D. J., & Voors, A. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq168 · Cited by 77
Calcium antagonists as inhibitors ofin vitro low density lipoprotein oxidation and glycation
Sobal, G., Menzel, E. J., & Sinzinger, H. F. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00548-7 · Cited by 68
Soluble Receptor for Advanced Glycation End Products (RAGE) is a Prognostic Factor for Heart Failure
Koyama, Y., Takeishi, Y., Niizeki, T., Suzuki, S., Kitahara, T., Sasaki, T., & Kubota, I. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.10.019 · Cited by 68
Raposeiras‐Roubín, S., Rodiño‐Janeiro, B. K., Grigorian-Shamagian, L., Moure‐González, M., Seoane‐Blanco, A., Roman, A. V., Álvarez, E., & González‐Juanatey, J. R. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq117 · Cited by 64
Campbell, D. J., Somaratne, J., Jenkins, A. J., Prior, D., Yii, M. Y., Kenny, J. F., Newcomb, A. E., Schalkwijk, C. G., Black, M. J., & Kelly, D. J. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-80 · Cited by 63
Piarulli, F., Sartore, G., Ceriello, A., Ragazzi, E., Reitano, R., Nollino, L., Cosma, C., Fedele, D., & Lapolla, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1367-y · Cited by 62
Mizutani, K.-I., Ikeda, K., Tsuda, K., & Yamori, Y. (2002) · Journal of Hypertension · doi:10.1097/00004872-200208000-00024 · Cited by 54
Yeboah, F. K., Alli, I., Yaylayan, V. A., Konishi, Y., Chowdhury, S. F., & Purisima, E. O. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034083v · Cited by 49
Howard, M. J., & Smales, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501480200 · Cited by 41
Chen, A.-S., Taguchi, T., SUGIURA, M., Wakasugi, Y., Kamei, A., Wang, M., & Miwa, I. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-814344 · Cited by 40
Diabetic heart disease: clinical considerations
Timmis, A. (2001) · Heart · doi:10.1136/heart.85.4.463 · Cited by 39
Raposeiras‐Roubín, S., Rodiño‐Janeiro, B. K., Grigorian-Shamagian, L., Moure‐González, M., Seoane‐Blanco, A., Roman, A. V., Bonet, L. A., Álvarez, E., & González‐Juanatey, J. R. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.11.011 · Cited by 34
Farhey, Y., & Hess, E. V. (1997) · Lupus · doi:10.1177/096120339700600704 · Cited by 33
Pentosidine – A New Biochemical Marker in Diabetic Retinopathy
Salman, A. G., Mansour, D. E. A. A., Swelem, A. H. A. M., et al. (2009) · Ophthalmic Research · doi:10.1159/000225661 · Cited by 29
Choi, E., Kwon, H. M., Ahn, C. W., Lee, G. T., Joung, B., Hong, B., Yoon, Y. W., Kim, D., Byun, K.-H., Kang, T. S., et al. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.1.78 · Cited by 28
Identification of the Rage-dependent gene regulatory network in a mouse model of skin inflammation
Riehl, A., Bauer, T., Brors, B., Busch, H. S., Mark, R., Németh, J., Gebhardt, C., Bierhaus, A., Nawroth, P. P., Eils, R., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-537 · Cited by 24
Steine, K., Larsen, J. R., Stugaard, M., Berg, T. J., Brekke, M., & Dahl‐Jørgensen, K. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.07.013 · Cited by 22
Norlinah, M., Hamizah, R., Isa, S. H. M., Nazaimoon, W. M. W., & Khalid, B. A. K. (2009) · Indian Journal of Medical Sciences · doi:10.4103/0019-5359.49365 · Cited by 8
Cited by
Twarda-Clapa, A., Olczak, A., Białkowska, A. M., & Koziołkiewicz, M. (2022) · Cells · doi:10.3390/cells11081312 · Cited by 746
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S., & Kalantar, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01582 · Cited by 581
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Stirban, A., Gawlowski, T., & Roden, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.006 · Cited by 361
Epidemiology of peritoneal dialysis outcomes
Bello, A. K., Okpechi, I. G., Osman, M. A., Cho, Y., Cullis, B., Htay, H., Jha, V., Makusidi, M. A., McCulloch, M., Shah, N., et al. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00623-7 · Cited by 264
Gut microbiota, immune development and function
Bengmark, S. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.09.002 · Cited by 262
Metadata
- Authors
- Hegab, Z.
- Venue
- World Journal of Cardiology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2012
- Volume
- 4
- Issue
- 4
- Pages
- 90
- ISSN
- 1949-8462 (ISSN-L)
- OpenAlex
- W2107243407
- Cited by
- 354
- References
- 130
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.